Advanced

EPR assessment of protein sites for incorporation of Gd(III) MRI contrast labels.

Lagerstedt, Jens LU ; Petrlova, Jitka LU ; Hilt, Silvia ; Marek, Antonin ; Chung, Youngran ; Sriram, Renuka ; Budamagunta, Madhu S ; Desreux, Jean F ; Thonon, David and Jue, Thomas , et al. (2013) In Contrast Media & Molecular Imaging 8(3). p.252-264
Abstract
We have engineered apolipoprotein A-I (apoA-I), a major protein constituent of high-density lipoprotein (HDL), to contain DOTA-chelated Gd(III) as an MRI contrast agent for the purpose of imaging reconstituted HDL (rHDL) biodistribution, metabolism and regulation in vivo. This protein contrast agent was obtained by attaching the thiol-reactive Gd[MTS-ADO3A] label at Cys residues replaced at four distinct positions (52, 55, 76 and 80) in apoA-I. MRI of infused mice previously showed that the Gd-labeled apoA-I migrates to both the liver and the kidney, the organs responsible for HDL catabolism; however, the contrast properties of apoA-I are superior when the ADO3A moiety is located at position 55, compared with the protein labeled at... (More)
We have engineered apolipoprotein A-I (apoA-I), a major protein constituent of high-density lipoprotein (HDL), to contain DOTA-chelated Gd(III) as an MRI contrast agent for the purpose of imaging reconstituted HDL (rHDL) biodistribution, metabolism and regulation in vivo. This protein contrast agent was obtained by attaching the thiol-reactive Gd[MTS-ADO3A] label at Cys residues replaced at four distinct positions (52, 55, 76 and 80) in apoA-I. MRI of infused mice previously showed that the Gd-labeled apoA-I migrates to both the liver and the kidney, the organs responsible for HDL catabolism; however, the contrast properties of apoA-I are superior when the ADO3A moiety is located at position 55, compared with the protein labeled at positions 52, 76 or 80. It is shown here that continuous wave X-band (9 GHz) electron paramagnetic resonance (EPR) spectroscopy is capable of detecting differences in the Gd(III) signal when comparing the labeled protein in the lipid-free with the rHDL state. Furthermore, the values of NMR relaxivity obtained for labeled variants in both the lipid-free and rHDL states correlate to the product of the X-band Gd(III) spectral width and the collision frequency between a nitroxide spin label and a polar relaxation agent. Consistent with its superior relaxivity measured by NMR, the rHDL-associated apoA-I containing the Gd[MTS-ADO3A] probe attached to position 55 displays favorable dynamic and water accessibility properties as determined by X-band EPR. While room temperature EPR requires >1 m m Gd(III)-labeled and only >10 µ m nitroxide-labeled protein to resolve the spectrum, the volume requirement is exceptionally low (~5 µl). Thus, X-band EPR provides a practical assessment for the suitability of imaging candidates containing the site-directed ADO3A contrast probe. Copyright © 2013 John Wiley & Sons, Ltd. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Contrast Media & Molecular Imaging
volume
8
issue
3
pages
252 - 264
publisher
Wiley-Blackwell
external identifiers
  • wos:000318041700006
  • pmid:23606429
  • scopus:84876786430
  • pmid:23606429
ISSN
1555-4317
DOI
10.1002/cmmi.1518
language
English
LU publication?
yes
id
ee3a53a7-d4d9-40b2-9144-9a362e42c3cd (old id 3733502)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23606429?dopt=Abstract
date added to LUP
2016-04-01 11:08:51
date last changed
2020-01-12 07:22:20
@article{ee3a53a7-d4d9-40b2-9144-9a362e42c3cd,
  abstract     = {We have engineered apolipoprotein A-I (apoA-I), a major protein constituent of high-density lipoprotein (HDL), to contain DOTA-chelated Gd(III) as an MRI contrast agent for the purpose of imaging reconstituted HDL (rHDL) biodistribution, metabolism and regulation in vivo. This protein contrast agent was obtained by attaching the thiol-reactive Gd[MTS-ADO3A] label at Cys residues replaced at four distinct positions (52, 55, 76 and 80) in apoA-I. MRI of infused mice previously showed that the Gd-labeled apoA-I migrates to both the liver and the kidney, the organs responsible for HDL catabolism; however, the contrast properties of apoA-I are superior when the ADO3A moiety is located at position 55, compared with the protein labeled at positions 52, 76 or 80. It is shown here that continuous wave X-band (9 GHz) electron paramagnetic resonance (EPR) spectroscopy is capable of detecting differences in the Gd(III) signal when comparing the labeled protein in the lipid-free with the rHDL state. Furthermore, the values of NMR relaxivity obtained for labeled variants in both the lipid-free and rHDL states correlate to the product of the X-band Gd(III) spectral width and the collision frequency between a nitroxide spin label and a polar relaxation agent. Consistent with its superior relaxivity measured by NMR, the rHDL-associated apoA-I containing the Gd[MTS-ADO3A] probe attached to position 55 displays favorable dynamic and water accessibility properties as determined by X-band EPR. While room temperature EPR requires >1 m m Gd(III)-labeled and only >10 µ m nitroxide-labeled protein to resolve the spectrum, the volume requirement is exceptionally low (~5 µl). Thus, X-band EPR provides a practical assessment for the suitability of imaging candidates containing the site-directed ADO3A contrast probe. Copyright © 2013 John Wiley & Sons, Ltd.},
  author       = {Lagerstedt, Jens and Petrlova, Jitka and Hilt, Silvia and Marek, Antonin and Chung, Youngran and Sriram, Renuka and Budamagunta, Madhu S and Desreux, Jean F and Thonon, David and Jue, Thomas and Smirnov, Alex I and Voss, John},
  issn         = {1555-4317},
  language     = {eng},
  number       = {3},
  pages        = {252--264},
  publisher    = {Wiley-Blackwell},
  series       = {Contrast Media & Molecular Imaging},
  title        = {EPR assessment of protein sites for incorporation of Gd(III) MRI contrast labels.},
  url          = {http://dx.doi.org/10.1002/cmmi.1518},
  doi          = {10.1002/cmmi.1518},
  volume       = {8},
  year         = {2013},
}